Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Allergan, Inc.
Ruth de Jauregui
| Apr 22, 2017
Novartis teaming with Allergan in Phase IIb trial of non-alcoholic steatohepatitis treatment therapy
Tabitha Fleming
| Jan 24, 2017
Allergan continues support for headache research
Jamie Barrand
| Mar 20, 2016
New treatment available for bipolar disorder, schizophrenia
Jamie Barrand
| Mar 17, 2016
Allergan's dry eye disease therapy receives prior approval supplement from FDA
Jamie Barrand
| Dec 17, 2015
Allergan releases new therapy for irritable bowel syndrome
Jamie Barrand
| Dec 7, 2015
Allergan partners with Rugen Therapeutics to develop autism, OCD therapies
Jamie Barrand
| Oct 16, 2015
Amgen, Allergan launch Phase 3 study of biosimilar candidate ABP 215
Jamie Barrand
| Oct 14, 2015
Allergan releasing generic version of Invega in U.S.
Trending
+
Marketing
Patient Daily
| Apr 22, 2024
Medfluence Senior Director of Business Development on healthcare marketing: 'Patient experience matters more than ever in patient acquisition'
+
Pharmaceuticals
Patient Daily
| Apr 24, 2024
Researchers Look for Long-Term Hearing Loss Treatments
+
Pharmaceuticals
Patient Daily
| Apr 24, 2024
American Lung Association Report: Utah Receives Poor Grades for Ozone and Particle Pollution
+
Pharmaceuticals
Patient Daily
| Apr 23, 2024
Kentucky Father with Terminal Lung Cancer Now Cancer-Free After Innovative Double-Lung Transplant at Northwestern Medicine